Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/19/2025

Treatment Algorithm for Anxiety, PTSD, and Psychotic Symptoms

Immediate Safety Assessment and Stabilization

  • The presence of psychotic symptoms warrants emergency evaluation by a licensed mental health professional, and if imminent risk of harm to self or others is present, initiate emergency psychiatric evaluation and ensure a safe environment with one-to-one observation, as recommended by the American Psychiatric Association 1

Primary Treatment: Initiate Trauma-Focused Psychotherapy Immediately

  • The American College of Psychiatrists recommends beginning trauma-focused psychotherapy as first-line treatment without requiring prolonged stabilization, even with comorbid psychotic symptoms, with evidence demonstrating safety and efficacy in this population 2, 3
  • Prolonged Exposure (PE), Cognitive Processing Therapy (CPT), or Eye Movement Desensitization and Reprocessing (EMDR) are equally effective first-line options, with 40-87% of patients no longer meeting PTSD criteria after 9-15 sessions, according to the International Society for Traumatic Stress Studies 2, 3

Pharmacotherapy: Concurrent SSRI Treatment

  • The American Psychiatric Association recommends initiating an SSRI (sertraline 50-200 mg/day or paroxetine 20-50 mg/day) as first-line pharmacotherapy for PTSD, which can be started concurrently with psychotherapy, with evidence demonstrating efficacy in maintaining response over 52 weeks 2
  • Continue SSRI treatment for a minimum of 6-12 months after symptom remission, as discontinuation leads to 26-52% relapse rates compared to only 5-16% when maintained on medication, as recommended by the National Institute of Mental Health 2

Anxiety Symptom Management

  • The American College of Psychiatrists recommends that the SSRI and trauma-focused psychotherapy will address generalized anxiety symptoms, and avoid benzodiazepines entirely, as they worsen PTSD outcomes, with 63% of patients receiving benzodiazepines developing PTSD at 6 months compared to only 23% receiving placebo 2, 3

Expected Outcomes

  • PTSD symptoms: 40-87% remission after completing trauma-focused therapy, according to the International Society for Traumatic Stress Studies 2
  • Anxiety and depression: generally improve following trauma-focused psychotherapy without requiring separate interventions, as recommended by the National Institute of Mental Health 2, 4
  • Relapse prevention: lower relapse rates after completing psychotherapy compared to medication discontinuation, according to the American Psychiatric Association 2, 4

REFERENCES

2

Treatment of Post-Traumatic Stress Disorder (PTSD) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

3

Treatment of Paranoid Personality Disorder with Trauma [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Treatment of Depression with Severe PTSD [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025